Qube Research & Technologies (QRT)’s Frontline FRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.8M Sell
684,858
-92,284
-12% -$3.39M 0.02% 826
2026
Q1
$27.1M Buy
777,142
+649,967
+511% +$19.9M 0.03% 703
2025
Q4
$2.77M Buy
+127,175
New +$2.97M ﹤0.01% 2100
2024
Q3
Sell
-52,657
Closed -$1.36M 3574
2024
Q2
$1.36M Buy
+52,657
New +$1.34M ﹤0.01% 1773
2024
Q1
Sell
-614,337
Closed -$12.3M 4604
2023
Q4
$12.3M Buy
614,337
+505,723
+466% +$10.5M 0.02% 662
2023
Q3
$2.04M Sell
108,614
-647,859
-86% -$10.9M 0.01% 1373
2023
Q2
$11M Buy
+756,473
New +$11.3M 0.04% 514
2022
Q2
Sell
-10,561
Closed -$93K 2703
2022
Q1
$93K Buy
+10,561
New +$83.6K ﹤0.01% 2085

Other funds holding FRO

Qube Research & Technologies (QRT)'s FRO Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Frontline (FRO) stake by 12% in Q2 2026, selling an estimated $3.39M and leaving 684,858 shares worth $23.8M. The position accounts for 0.02% of the portfolio, ranked #826.

Qube Research & Technologies (QRT) first reported a position in FRO in Q1 2022 and has held it in 8 quarters since. The position peaked at $27.1M in Q1 2026. 261 funds tracked by Wall St. Rank hold FRO as of Q2 2026.

  • Qube Research & Technologies (QRT) held 684,858 shares of Frontline worth $23.8M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 92,284 Frontline shares in Q2 2026, an estimated $3.39M.
  • Frontline made up 0.02% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #826 holding.
  • Qube Research & Technologies (QRT) first reported a position in Frontline in Q1 2022 and has held it in 8 quarters since.
  • Qube Research & Technologies (QRT)'s Frontline position peaked at $27.1M in Q1 2026.
  • 261 funds tracked by Wall St. Rank held Frontline as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.